Get started

AUROPHARMA

Bullish Momentum Revival Near Key Support | STWP💹 Aurobindo Pharma Ltd (NSE: AUROPHARMA) Sector: Pharmaceuticals | CMP: ₹1,138.90 | View: Bullish Momentum Setup 📊 Price Action: Aurobindo Pharma shows strong bullish momentum after reclaiming key support zones near ₹1,100. The stock has printed a bullish engulfing candle with institutional-grade volume, signaling a potential continuation of the uptrend. Price action confirms demand absorption at lower levels with buyers defending the ₹1,080–1,100 zone effectively. 💼 HNI Trade Levels (STWP Setup): Aggressive Entry: ₹1,138.90–₹1,155.80 | Stop Loss: ₹1,087.35 Low-Risk Entry: ₹1,137.12 | Stop Loss: ₹1,080.02 The STWP HNI Setup reflects a well-defined bullish structure supported by EMA 200 crossover and strong candle confirmation. Smart money activity is visible through expanding volume footprints and VCP contraction signs fading toward breakout. 📉 VCP Analysis: Aurobindo Pharma has undergone 112 VCP contractions, forming a tight base before breakout attempts. Although the current candle is yet to confirm a clean VCP breakout, the setup suggests a pre-breakout stage, aligning with institutional interest. The ongoing contraction phase combined with a bullish RSI breakout supports accumulation by strong hands. 📈 STWP Trading Analysis: Entry: ₹1,155.80 | Stop Loss: ₹1,098.70 | Risk: ₹57.10 The bullish structure is reinforced by a 5x volume expansion and a strong buyer-dominated candle. EMA 200 crossover, MACD bullish alignment, and RSI strength above 52 confirm upside bias. Holding above ₹1,120 keeps the short-term structure firmly bullish toward ₹1,177–₹1,208 levels. 📏 Fibonacci Analysis: From the swing low of ₹1,016.10 to the recent swing high of ₹1,208.20 — price currently hovers around the 61.8% retracement zone at ₹1,134.82, a critical Fibonacci pivot. Sustaining above this level indicates strength and supports the ongoing uptrend. Fibonacci extensions project targets near ₹1,208–₹1,218 on breakout confirmation. 🧭 STWP Support & Resistance: Resistances: ₹1,163.13 | ₹1,187.37 | ₹1,218.93 Supports: ₹1,107.33 | ₹1,075.77 | ₹1,051.53 The ₹1,075–₹1,107 zone serves as a strong institutional support, aligning with prior demand clusters. Weak resistance pockets lie between ₹1,163–₹1,208, opening space for a clean momentum push if price sustains above ₹1,155. 📊 STWP Volume & Technical Setup: Today’s volume surged to 3.56M vs 1.3M average, confirming high institutional participation. The chart highlights multiple technical confirmations — a strong EMA crossover, momentum breakout, and volatility expansion supported by a bullish candle formation. Key momentum oscillators are turning upward, reflecting renewed strength and sustained bullish bias across timeframes. 🧩 STWP Summary View: Final Outlook: Momentum: Strong | Trend: Uptrend | Risk: High| Volume: High Aurobindo Pharma is exhibiting robust institutional footprints with trend confirmation across all major indicators. As long as the price holds above ₹1,107–₹1,120, the structure remains intact with scope for a short-term move toward ₹1,177–₹1,208. The bias remains bullish with uptrend continuation potential into the next few sessions. ⚠️ Disclosure & Disclaimer – Please Read Carefully This post is shared only for educational and informational purposes. It is not a buy/sell recommendation or financial advice. I am not a SEBI-registered investment adviser; all views are based on technical observation and public market data. Trading involves risk. Market movements can be unpredictable and may result in losses. Always perform your own research or consult a SEBI-registered financial advisor before trading. Position Status: No active position in (AUROPHARMA) at the time of this analysis. Data Source: TradingView & NSE India 💬 Found this useful? 🔼 Give this post a Boost if you value structured, professional breakdowns. ✍️ Share your thoughts or charts below — let’s learn together! 🔁 Spread this post to help more traders adopt data-driven analysis. 👉 Follow for more clean, institutional-style setups with clarity and discipline. 🚀 Stay Calm. Stay Clean. Trade With Patience. Trade Smart | Learn Zones | Be Self-Reliant 📊
NSE:AUROPHARMALong
by simpletradewithpatience
Aurobindo Pharma – Strong Core, Next Growth AheadNSE:AUROPHARMA 🔹 Fundamental Overview Aurobindo Pharma is a diversified, integrated pharmaceutical company with a strong presence in generics, APIs, and specialty formulations, operating across over 150 countries. Market Capitalization: Around ₹65,000 crore—a large-cap pharma player with stable earnings visibility. Valuation: Trades at a P/E of about 18–19× and P/B near 2×, making it fairly valued compared to peers. Profitability: Return on Equity (ROE) around 10–11% and Net Profit Margin near 10%, reflecting steady but moderate profitability. Balance Sheet Strength: Low leverage with Debt-to-Equity ratio of roughly 0.25, highlighting financial discipline. Growth Trend: Revenues and earnings have shown consistent moderate growth, with recent improvement in operating margins driven by cost control and new product launches. Dividend Policy: Low dividend payout; management prioritizes reinvestment and expansion. Strengths: vertically integrated model, global footprint, diversified product portfolio, and strong R&D capabilities. Risks: Regulatory scrutiny (especially in the USFDA space), pricing pressure in generic markets, and raw material cost volatility. 🔹 Technical Overview Trend Direction: The stock maintains a bullish to neutral bias, trading above its 50-day and 200-day moving averages, showing medium-term strength. Momentum: RSI near 55–60, suggesting balanced momentum without overbought signs. Trend Strength: ADX around 30 indicates a healthy ongoing trend; MACD remains in positive territory, supporting upward bias. Support Levels: Strong base between ₹1,030 and ₹1,070, ideal zone for accumulation. Resistance Levels: Key resistance lies around ₹1,120 – ₹1,150; a breakout above this range may trigger sustained upside. Long-Term Projection: On a 3–5-year horizon, strong fundamentals and sector growth could drive price toward ₹2,500+. Risk Management: Maintain stop-loss near ₹1,000 to safeguard capital; trail stops as price advances beyond ₹1,200. 🔹 Investor Takeaway Outlook: Aurobindo Pharma combines financial stability, diversified revenue, and steady earnings visibility—well-positioned for long-term growth. Strategy: Accumulate on dips near support zones and add on breakouts above ₹1,150 with confirmation. Investment Horizon: Suitable for investors seeking medium-to-long-term exposure (1–5 years) in India’s resilient pharmaceutical sector. Risk Profile: Moderate—best for investors comfortable with regulatory and currency-related volatilities. ======================== ======================== ⚠️ Disclaimer: This analysis is for educational and informational purposes only. We are not SEBI-registered analysts or advisors. This is our personal view based on available data and market trends. Please consult your SEBI-registered investment advisor before making any investment or trading decisions. You are solely responsible for any financial decisions you make based on this content. ======================== Trade Secrets By Pratik ========================
NSE:AUROPHARMALong
by Trade_Secrets_By_Pratik
AUROPHARMA | Bullish Cup & Handle Breakout Setup________________________________________ 🚀 Aurobindo Pharma Ltd (NSE: AUROPHARMA) | Bullish Cup & Handle Breakout Setup 📊 Current Market Snapshot CMP: ₹1,119.90 Sector: Pharmaceuticals / Healthcare Pattern Observed: ☕ Cup & Handle Breakout Formation Candlestick Signal: Strong Bullish Candle + Volume Expansion Strength Rating: ⭐⭐⭐⭐☆ (Bullish Breakout Confirmation) ________________________________________ 🧭 Technical Overview Aurobindo Pharma has formed a classic Cup and Handle pattern, signaling trend reversal and continuation strength. After a steady base formation over the past few months, the stock has broken out above its neckline near ₹1,120 with a powerful bullish candle and rising volume — a strong indicator of institutional buying. The cup represents accumulation, while the handle reflects a healthy consolidation before breakout. The volume spike (~4.9M) and RSI breakout confirm momentum strength, supported further by: ✅ Bullish VWAP ✅ BB Squeeze-On Compression (volatility expansion) ✅ Fake Breakdown Recovery (liquidity sweep) These signals collectively validate a bullish structure with potential upside continuation as long as the price sustains above ₹1,120. ________________________________________ 📊 Trade Setup (Cup & Handle Breakout) Entry: ₹1,126.30 Stop Loss: ₹1,066.80 Resistance: 1132/1145/1164 Support: 1101/1082/1070 Risk/Reward Ratio: 1 : 1 | 1:2 Volume: 4.94M (Above Average) ________________________________________ 💡 Learning Note This pattern is a textbook Cup and Handle breakout, one of the most reliable continuation patterns in technical analysis. The rounded base (cup) indicates accumulation, while the short handle shows minor profit booking before renewed buying strength. A decisive breakout above the neckline with volume surge confirms trend continuation — a great example of how volume + pattern confluence can guide traders toward high-probability setups. ________________________________________ ⚠️ Disclosure & Disclaimer – Please Read Carefully The information shared here is meant purely for learning and awareness. It is not a buy or sell recommendation and should not be taken as investment advice. I am not a SEBI-registered investment adviser, and all views expressed are based on personal study, chart patterns, and publicly available market data. Position Status: No active position in Aurobindo Pharma at the time of analysis. Data Source: TradingView & NSE India (Past Chart Reference) (Historical levels) Trading — whether in stocks or options — carries risk. Markets can move unexpectedly, and losses can sometimes exceed the capital you have invested. Past performance or setups do not guarantee future results. If you are a beginner, treat this as a learning example and practice with paper trades before risking real money. If you are experienced, always assess your own risk, position sizing, and strategy suitability before entering trades. Consult a SEBI-registered financial adviser before making any real trading decision. By engaging with this content, you acknowledge full responsibility for your trades and investments. ________________________________________ 💬 Found this useful? 🔼 Give this post a Boost to help more traders discover structured learning. ✍️ Drop your thoughts, questions, or setups in the comments — let’s grow together! 🔁 Share with fellow traders and beginners to spread awareness. 👉 “If you liked this breakdown, follow for more clean, structured setups with discipline at the core.” 🚀 Stay Calm. Stay Clean. Trade With Patience. Trade Smart | Learn Zones | Be Self-Reliant 📊 ________________________________________
NSE:AUROPHARMALong
by simpletradewithpatience
F&O Watchlist – Stocks with Action👋 Hello Traders! Welcome to the Daily Options Trade Setup & Watchlist – 12th Sept 2025 🚀 The market is showing strong activity today with fresh long build-ups, surging volumes, and supportive OI data across key F&O names. Volatility remains balanced, creating opportunities for traders to ride the momentum while keeping risks in check. This watchlist highlights stocks where data and trend are aligning, giving us a clearer picture of market sentiment and possible trading setups. Let’s explore today’s opportunities 👇 ADANIENT | 11th Sept 2025 Overall Bias: Bullish Spot Price: ₹2,446.50 Trend: Uptrend Volatility: Moderate (IV ~24–25%) Ideal Strategy Mix: Directional Bullish + OTM Convexity + Hedge via PE ________________________________________ ✅ Bullish Trade (Naked options as per trend) ADANIENT 2450 CE LTP @ ₹34.45 Why: Long Build-up at 2450 CE → OI ↑ 173% with Price ↑ 118% (strong confirmation). Volume surge 986% → heavy participation. Delta 0.46 → balance of ITM probability & convexity. Rising IV (5.9%) → supports premium expansion. ________________________________________ ⚠️ Contrarian Trade (Naked options against trend) ADANIENT 2300 PE LTP @ ₹21.50 Why: Acts as a downside hedge in case of reversal. IV 28.7% with IV ↑ 26.8% → room for premium spike. Delta -0.33 → controlled risk hedge. Suitable for protection if momentum stalls. ________________________________________ 🎯 Strategy Trade (As per trend + OI data) Bull Call Spread → 2450 CE LTP @ ₹34.45 & 2550 CE LTP @ ₹10.75 Why: • Aligns with strong bullish OI build-up (2400–2600 CE cluster). • Captures upside momentum with defined risk. • Excellent R:R (1:3+) → low cost, high potential reward. • Short CE hedge (2550) cuts theta decay and risk. ________________________________________ ________________________________________ ADANIPORTS | 11th Sept 2025 Overall Bias: Bullish Spot Price: ~₹1,438 (near 1440 zone) Trend: Uptrend Volatility: Moderate (IV ~23–26%) Ideal Strategy Mix: Directional Bullish + OTM Convexity + Hedge via PE ________________________________________ ✅ Bullish Trade (Naked options as per trend) ADANIPORTS 1440 CE LTP @ ₹13.90 Why: Long Build-up at 1440 CE → OI ↑ 100.6% with Price ↑ 50.3% (classic long-side confirmation). Volume surge 524.5% → strong participation. Delta 0.39 → sweet spot between ITM probability & convexity. IV rising 20.7% → supportive of premium expansion. ________________________________________ ⚠️ Contrarian Trade (Naked options against trend) ADANIPORTS 1400 CE LTP @ ₹27.90 (used here as hedge/play on exhaustion) Why: Higher ITM CE with Delta 0.51 → limited convexity, may underperform if momentum slows. OI ↑ only 12.3% → weaker build-up compared to mid-OTM strikes. IV 23.0% (low side) → less premium expansion potential. Can act as a contrarian hedge if market consolidates below 1440. ________________________________________ 🎯 Strategy Trade (As per trend + OI data) Bull Call Spread → ADANIPORTS 1440 CE LTP @ ₹13.90 & 1500 CE LTP @ ₹4.95 Why: • Strong long build-ups across 1420–1460 strikes → confirms directional bias. • Captures upside momentum with defined risk using OTM convexity (1500 CE). • Excellent R:R (≈ 1:2+) → low debit, higher potential payoff. • Short OTM CE (1500) reduces theta decay and caps risk. ________________________________________ ________________________________________ AUROPHARMA | 11th Sept 2025 Overall Bias: Bullish Spot Price: ~₹1,118 (near 1120 zone) Trend: Uptrend Volatility: Rich (IV ~30–32%) Ideal Strategy Mix: Bullish Directional + Debit Spreads (IV hedging) + Convexity via OTM Calls ________________________________________ ✅ Bullish Trade (Naked options as per trend) AUROPHARMA 1140 CE LTP @ ₹18.95 Why: Long Build-up → Price ↑ 351% with OI ↑ 280% (strong long confirmation). Volume surge 1792% → very active participation. Delta 0.40 → sweet convexity with good ITM odds. IV rising 6.2% → supports premium expansion. ________________________________________ ⚠️ Contrarian Trade (Naked options against trend) AUROPHARMA 1060 CE LTP @ ₹64.25 (deep ITM hedge / slowdown risk) Why: Short covering at 1060 CE (OI ↓ 15.8%) → weaker continuation if fresh longs don’t add. Higher ITM delta (0.74) → less convexity, less reward-to-risk. IV rich (31.6%) → premiums already expensive. Could underperform if price momentum cools off near resistance zones. ________________________________________ 🎯 Strategy Trade (As per trend + OI data) Bull Call Spread → AUROPHARMA 1120 CE LTP @ ₹26.65 & 1160 CE LTP @ ₹13.10 Why: • Strong long build-ups between 1120–1160 strike cluster confirm bullish continuation. • Captures upside momentum with limited debit exposure. • IV ~30+ → spreads preferred over naked calls (reduces risk of IV crush). • Good convexity → balance of ITM probability and upside leverage. ________________________________________ ________________________________________ HAL | 11th Sept 2025 Overall Bias: Bullish Spot Price: ~₹4,650 (near 4600–4700 zone) Trend: Uptrend Volatility: Moderate (IV ~25–28%) Ideal Strategy Mix: Directional Bullish + OTM Convexity + Debit Spreads for IV balance ________________________________________ ✅ Bullish Trade (Naked options as per trend) HAL 4800 CE LTP @ ₹36.10 Why: Long Build-up → Price ↑ 16.8% with OI ↑ 7% (fresh long confirmation). Volume surge 72.5% → active participation. Delta 0.34 → balance of convexity & ITM probability. IV 25.7% → stable with upside potential. ________________________________________ ⚠️ Contrarian Trade (Naked options against trend) HAL 4500 CE LTP @ ₹158.55 (short covering driven, contrarian hedge) Why: Short covering at 4500 CE → OI ↓ 13.7% while Price ↑ 12.8%. Delta 0.61 → deeper ITM, lower convexity. Volume dropped 56% → thinner liquidity, size should be reduced. Better suited as hedge / risk balancer in case momentum stalls. ________________________________________ 🎯 Strategy Trade (As per trend + OI data) Bull Call Spread → HAL 4800 CE LTP @ ₹36.10 & 4900 CE LTP @ ₹21.00 Why: • OI build-up across 4700–4900 CE cluster confirms bullish continuation. • Debit spread reduces IV risk (IV ~25–27%) and limits loss. • Defined-risk setup with convexity at 4900 CE. • Cleaner R:R profile compared to naked long calls. ________________________________________ ________________________________________ TCS | 11th Sept 2025 Overall Bias: Bullish Spot Price: ~₹3,135 (near 3140 zone) Trend: Uptrend Volatility: Moderate (IV ~17–19%) Ideal Strategy Mix: Directional Bullish + OTM Convexity + Debit Spread to balance low IV ________________________________________ ✅ Bullish Trade (Naked options as per trend) TCS 3200 CE LTP @ ₹25.05 Why: Long Build-up → Price ↑ 9.2% with OI ↑ 7.9% (long confirmation). IV 17.9% → moderate, stable for option buying. Delta 0.36 → sweet spot of convexity & ITM odds. Fits directional bullish bias near resistance breakouts. ________________________________________ ⚠️ Contrarian Trade (Naked options against trend) TCS 3100 CE LTP @ ₹67.85 (short covering driven, weaker momentum trade) Why: Short covering at 3100 CE → OI ↓ 4% while Price ↑ 6.1%. Volume dropped 72.5% → thin liquidity, size down. IV 17.2% easing -5.3% → weaker premium expansion. Higher ITM delta (0.59) → less convexity, limited upside gearing. ________________________________________ 🎯 Strategy Trade (As per trend + OI data) Bull Call Spread → TCS 3200 CE LTP @ ₹25.05 & 3300 CE LTP @ ₹8.25 Why: • Strong long build-ups in 3140–3200 CE cluster confirm bullish continuation. • Low IV environment (17–19%) → debit spreads attractive. • Defined-risk setup with convexity via OTM CE (3300). • Good balance of premium outlay vs reward with capped downside. ________________________________________ ________________________________________ 📘 My Trading Setup Rules Avoid Gap Plays → Check pre-open price action to avoid trades influenced by gap-ups/gap-downs. Breakout Entry Only → Enter trades only if price breaks previous day’s High (for bullish trades) or Low (for bearish trades). Watch Volume for Confirmation → Monitor volume closely. No volume = No trade. Enter on Strong Candle + Volume → Execute the trade only if a strong candle appears with increasing volume in the direction of the trade. Defined Risk:Reward Only → Take trades only if R:R is favorable (ideally ≥ 1:2). Premium Disclaimer → Option premiums shown are based on EOD prices — real-time premiums may vary during execution. Time Frame Preference → Trade with your preferred time frame — this strategy works across intraday or positional setups. ⚠️ Disclaimer – Please Read Carefully The information shared here is meant purely for learning and awareness. It is not a buy or sell recommendation and should not be taken as investment advice. I am not a SEBI-registered investment advisor, and all views expressed are based on personal study, chart patterns, and publicly available market data. Trading — whether in stocks or options — carries risk. Markets can move unexpectedly, and losses can sometimes exceed the money you have invested. Past performance or past setups do not guarantee future results. If you are a beginner, treat this as a guide to understand how the market works — practice on paper trades before risking real money. If you are experienced, always assess your own risk, position sizing, and strategy suitability before entering trades. Consult a SEBI-registered financial advisor before making any real trading decision. By engaging with this content, you acknowledge full responsibility for your trades and investments. 💬 Found this useful? 🔼 Give this post a Boost to help more traders discover clean, structured learning. ✍️ Drop your thoughts, questions, or setups in the comments — let’s grow together! 🔁 Share with fellow traders and beginners to spread awareness. 👉 “If you liked this breakdown, follow for more clean, structured setups with discipline at the core.” 🚀 Stay Calm. Stay Clean. Trade With Patience. Trade Smart | Learn Zones | Be Self-Reliant 📊
NSE:NIFTY
by simpletradewithpatience
1
Watchlist Analysis – 12th Sept 2025📊 Watchlist Analysis – 12th Sept 2025 ________________________________________ 📌 ADANIENT (2398.80) – Rising Wedge Momentum: Strong | Bullish | Risk: Low | Volume: High Important Resistance Levels: 2499.68 / 2580.66 | Stop Loss: 2337.72 📊 Technical Indicators Explained Adani Enterprises (ADANIENT) is flashing strong technical signals. A rising wedge structure 🔺 shows price tightening towards resistance, with today’s bullish breakout candle 🔥 backed by heavy volume surge 🚀. The RSI breakout ⚡ confirms strengthening momentum, while the BB Squeeze-Off release 📊 hints at a fresh volatility expansion. With support zones holding firm and price eyeing higher resistances, the stock is entering a decisive breakout zone. Support & Resistance Zones 🟢 Support: 2353 | 2307 | 2275 🔴 Resistance: 2432 | 2464 | 2510 Investment Outlook & Conclusion 📈 Bullish Case – Strong momentum with volume support may push towards higher resistances. 📉 Bearish Case – A drop below SL can attract downside pressure. ⚡ Momentum Case – Aligned with momentum; good for short-term swings. 📅 Perspective – Short-term breakout play; long-term needs stability. ________________________________________ 📌 AUROPHARMA (1109.20) – Double Bottom Momentum: Strong | Bullish | Risk: High | Volume: High Important Resistance Levels: 1175.93 / 1233.96 | Stop Loss: 1059.87 📊 Technical Indicators Explained Aurobindo Pharma (AUROPHARMA) is flashing multiple bullish signals. A double bottom pattern 📉➡️📈 near ₹1016 confirms a strong reversal base, followed by a bullish breakout candle 🔥 backed by massive volume surge 🚀. The RSI breakout ⚡, Bollinger Band expansion 📊, and SuperTrend flip ✅ add conviction to the momentum. With supports holding firm and resistances ahead, the stock is entering a high-probability breakout zone. Support & Resistance Zones 🟢 Support: 1074 | 1040 | 1018 🔴 Resistance: 1131 | 1153 | 1189 Investment Outlook & Conclusion 📈 Bullish Case – Heavy volume breakout supports upside continuation. 📉 Bearish Case – Failure to sustain above 1080 can bring weakness. ⚡ Momentum Case – Strong near-term upside; suitable for aggressive traders. 📅 Perspective – Short- to medium-term; long-term investors should watch risk levels. ________________________________________ 📌 TATACHEM (968.25) - Symmetrical Triangle Momentum: Strong | Bullish | Risk: Low | Volume: High Resistance Levels: 1007.92 / 1039.84 | Stop Loss: 944.08 📊 Technical Indicators Explained Tata Chemicals (TATACHEM) is showing strong bullish signals forming a Symmetrical Triangle. A bullish engulfing candle 🔥 near support highlights renewed buying interest, while an RSI breakout ⚡ confirms strengthening momentum. The Bollinger Band breakout 📊, along with VWAP support ✅, suggests rising participation. With a recent BB squeeze compression 🎯 now opening up, volatility expansion could fuel a decisive move. The stock is positioned in a potential breakout zone 🚀 Support & Resistance Zones 🟢 Support: 950 | 932 | 919 🔴 Resistance: 981 | 994 | 1012 Investment Outlook & Conclusion 📈 Bullish Case – Triangle consolidation may resolve higher on breakout. 📉 Bearish Case – Below SL, stock could revisit support levels. ⚡ Momentum Case – Neutral-to-positive; volume confirmation needed. 📅 Perspective – Short-term breakout opportunity; medium-term cautious stance. ________________________________________ 📌 SHRIRAMFIN (620.05) – Downward Sloping Channel Momentum: Strong | Bullish | Risk: Low | Volume: High Resistance Levels: 643.69 / 664.48 | Stop Loss: 602.11 📊 Technical Indicators Explained Shriram Finance (SHRIRAMFIN) has given a downward sloping channel breakout 📉➡️📈, signaling a shift from weakness to strength. An RSI breakout ⚡ confirms bullish momentum, while a BB Squeeze-Off setup 🎯 points to potential volatility expansion. The bullish price action 🔥 backed by rising volumes 🚀 suggests renewed buyer confidence. With resistances overhead, the stock now stands at a critical breakout zone, where follow-through buying could unlock further upside. Support & Resistance Zones 🟢 Support: 608 | 595 | 588 🔴 Resistance: 628 | 635 | 648 Investment Outlook & Conclusion 📈 Bullish Case – Strong buying interest; scope for further upside. 📉 Bearish Case – Failure to hold above 602 may weaken momentum. ⚡ Momentum Case – Positive; traders may ride short-term moves. 📅 Perspective – Short-term play; long-term view requires caution. ________________________________________ ⚠️ Disclaimer – Please Read Carefully The information shared here is meant purely for learning and awareness. It is not a buy or sell recommendation and should not be taken as investment advice. I am not a SEBI-registered investment advisor, and all views expressed are based on personal study, chart patterns, and publicly available market data. Trading — whether in stocks or options — carries risk. Markets can move unexpectedly, and losses can sometimes exceed the money you have invested. Past performance or past setups do not guarantee future results. If you are a beginner, treat this as a guide to understand how the market works — practice on paper trades before risking real money. If you are experienced, always assess your own risk, position sizing, and strategy suitability before entering trades. Consult a SEBI-registered financial advisor before making any real trading decision. By engaging with this content, you acknowledge full responsibility for your trades and investments. 💬 Found this useful? 🔼 Give this post a Boost to help more traders discover clean, structured learning. ✍️ Drop your thoughts, questions, or setups in the comments — let’s grow together! 🔁 Share with fellow traders and beginners to spread awareness. 👉 “If you liked this breakdown, follow for more clean, structured setups with discipline at the core.” 🚀 Stay Calm. Stay Clean. Trade With Patience. Trade Smart | Learn Zones | Be Self-Reliant 📊
NSE:ADANIENTLong
by simpletradewithpatience
Aurobindo Pharma: Breakout with a Long Opportunity?Aurobindo Pharma is showing signs of a trend reversal on the daily chart. The stock has broken above a descending trendline, supported by strong volumes, signaling a potential bullish move. Key Levels to Watch: Support: ₹1,253 Resistance: ₹1,346 and ₹1,407 Long Opportunity: If the stock sustains above ₹1,300, it offers a good long opportunity with a target of ₹1,407 in the short term. A close above ₹1,407 could open doors to further upside. Traders can consider ₹1,253 as a stop-loss for a risk-managed entry. A decisive move above ₹1,346 will confirm bullish momentum, making this a promising setup for long-term gains.
NSE:AUROPHARMALong
by ayusharya_001
AUROBINDO PHARMA - Price is bouncing from demand⚡Price Analysis: 1️⃣ Stock is in bullish trend. 2️⃣ Price have hit the demand zone. 3️⃣ EMAs are also supporting the view. ✨ My Expectations: ➡️ RRR is favourable. ➡️ 1:3RRR minimum will be expected. Entered w/ 7% SL . ➡️ Expecting strong weekly candle closing for confirmation strength. ➡️ Overall market sentiment is weak so will stay cautious. ⚠️ Disclaimer: This is NOT a buy/sell recommendation. This post is meant for learning purposes only. Views are personal. Please, do your due diligence before investing.⚠️ 💬 Drop your thoughts below in the comments section if you liked this analysis!✌️ 🔥Happy trading!✅🚀
NSE:AUROPHARMALong
by SuperNova396
Aurobindo Pharma - Long Trade SetupHello, Auropharma near the resistance level of 1275 . You can enter long when price is crossed above 1275. *Confirmation of Trend Strength: A breakout above resistance indicates strong upward momentum and confirms the existing uptrend. This increases the likelihood of further price appreciation. * Reduced Risk: Trading with the trend minimizes the risk of opposing a large number of market participants who are also betting on the continuation of the uptrend. * Momentum: Breakouts often trigger a surge in buying pressure as traders rush to capitalize on the upward move, further propelling prices higher. * Clear Entry Signal: The breakout provides a well-defined entry point, allowing traders to enter the market with precision and confidence.
NSE:AUROPHARMALong
by piyushbafna000
Aurobindo Pharma - Long Trade SetupHello, Auropharma near the resistance level of 1275 . You can enter long when price is crossed above 1275. *Confirmation of Trend Strength: A breakout above resistance indicates strong upward momentum and confirms the existing uptrend. This increases the likelihood of further price appreciation. * Reduced Risk: Trading with the trend minimizes the risk of opposing a large number of market participants who are also betting on the continuation of the uptrend. * Momentum: Breakouts often trigger a surge in buying pressure as traders rush to capitalize on the upward move, further propelling prices higher. * Clear Entry Signal: The breakout provides a well-defined entry point, allowing traders to enter the market with precision and confidence.
NSE:AUROPHARMALong
by piyushbafna000
CNXPHARMA - Trend Reversal📊 Script: CNXPHARMA (NIFTY PHARMA) Key highlights: 💡⚡ 📈 Nifty Pharma is retesting from its support level shown in chart. 📈 Pharma stocks can give good returns. 📈 One can go for Swing Trade into Pharma stocks. 📊 Script: CIPLA ⏱️ C.M.P 📑💰- 1414 🟢 Target 🎯🏆 - 1510 📊 Script: LUPIN ⏱️ C.M.P 📑💰- 1688 ONLY ABOVE 1700 🟢 Target 🎯🏆 - 1828 📊 Script: AUROPHARMA ⏱️ C.M.P 📑💰- 1177 🟢 Target 🎯🏆 - 1267 📊 Script: GLAND ⏱️ C.M.P 📑💰- 1177 🟢 Target 🎯🏆 - 1267 📊 Script: BIOCON ⏱️ C.M.P 📑💰- 1177 🟢 Target 🎯🏆 - 1267 ⚠️ Important: Always maintain your Risk & Reward Ratio. ✅Like and follow to never miss a new idea!✅ Disclaimer: I am not SEBI Registered Advisor. My posts are purely for training and educational purposes. Eat🍜 Sleep😴 TradingView📈 Repeat 🔁 Happy learning with trading. Cheers!🥂
NSE:CNXPHARMALong
by radha_23
AUROPHARMA - Ichimoku BreakoutStock Name - Aurobindo Pharma Limited Ichimoku Cloud Setup : 1). Today's close is above the Conversion Line 2). Future Kumo is Turning Bullish 3). Chikou span is slanting upwards All these parameters are showing bullishness at Current Market Price and more bullishness AFTER crossing 765 #This is not Buy and Sell recommendation to any one. This is for education purpose and a helping hand to learn trading in Market. # Cloud Trading # Ichimoku Cloud # Ichimoku Followers I hope you all like my analysis. Please do share your thoughts into comment section. Please give a like, share & subscribe for daily analysis.
NSE:AUROPHARMALong
by nikunjbhadja
AUROPHARMA - Ichimoku Breakout Stock Name - Aurobindo Pharma Limited Ichimoku Cloud Setup : 1). Today's close is above the Conversion Line 2). Future Kumo is Turning Bullish 3). Chikou span is slanting upwards All these parameters are showing bullishness at Current Market Price and more bullishness AFTER crossing 702 #This is not Buy and Sell recommendation to any one. This is for education purpose and a helping hand to learn trading in Market. # Cloud Trading # Ichimoku Cloud # Ichimoku Followers I hope you all like my analysis. Please do share your thoughts into comment section. Please give a like, share & subscribe for daily analysis.
NSE:AUROPHARMALong
by nikunjbhadja
AUROPHARMA: Terminal ThrustUsually this wave structure forms in an impulsive sequence as wave 4 . It consists of 5 sub waves as wave-a , wave-b , wave-c, wave-d and a final setback wave-e . Each of these waves consists of three wave internal structure. Each of the waves should not break their extreme points. The final confirmation to enter the position comes when the price gets close above the level of wave-d. The minimum target of the pattern is just a poke above the level of wave-b and just above the level of wave-3 of the impulsive count. There is also a guideline to predict the target of this pattern which is known as triangular thrust. The triangular thrust is the measurement of the distance from the level of wave-a to the level of wave-b . This measured length should be kept at the point of completion of wave-e (conservative approach) or to the breakout level of wave-d to get the target of this pattern (aggressive approach). Triangles are the penultimate waves i.e. waves before the last wave. This suggests that prices have reached to level of exhaustion and are likely to take a reversal. In this particular case, Auropharma is likely to finish the Wave-3. A break of the green trendline will give the first signal that wave-3 has peaked. Trading strategy: Sell below 630 keeping Sl of the previous high before breaking the 630 on the downside and look for the target of 600/585 in the coming days/weeks.
NSE:AUROPHARMAShort
by TradingSutra
1